登录
注册
您所在的位置:首页>>报告>>报告详情

Prescription drug pricing: An overview of the legal, regulatory, ...

处方药定价:法律,法规和市场环境的概述

【作       者】:

{{d.作者}}

【机       构】: 美国企业公共政策研究所
【承研机构】:

【原文地址】: https://www.aei.org/research-products/report/prescription-drug-pricing-an-overview-of-the-legal-regulatory-and-market-environment/
【发表时间】:

2018-07-23

摘要

Abstract

Policy attention is now focused on prescription drug prices, which in some cases have grown sharply in recent years, and the financial burden that high prices can sometimes place on patients. The Trump administration has announced its intention to pursue changes in various policies to bring down prices or to slow their growth. The protection of intellectual property is an important component of dynamic economic growth and medical progress in the US. However, it does create pricing power for the inventors of new therapies, which in turn makes it difficult for policymakers to ensure access to effective care is within reach for all patients and is affordable for tax-subsidized programs. The pricing of prescription drugs occurs in a market influenced by a complex web of public policies and private-sector conventions that were assembled over many years on an ad hoc basis. These policies secure somewhat lower prices for some purchasers but likely raise the prices for others. While there are no simple solutions, policymakers should study the existing arrangements carefully and consider what can be done to promote more supply competition (thus minimizing monopolistic pricing) in all drug categories. They should also think creatively about how to promote more pricing leverage for consumers rather than adopt government price controls. The policy goal is to strengthen countervailing pressure from purchasers to negotiate better prices for consumers, rather than provide preferential pricing for narrow segments of the market.

Prescription Drug Pricing: An Overview of the Legal, Regulatory, and Market Environment

标签: {{b}}
展开